deltatrials
Completed NCT00002485

Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer

Barriers to Patient Enrollment Onto Frontline Therapeutic Clinical Trials and Development of Intervention Strategies to Increase the Proportion of Enrollment

Sponsor: Children's Oncology Group

Updated 6 times since 2017 Last updated: Feb 12, 2014 Started: Feb 29, 1992 Primary completion: Jul 31, 2003 Completion: Sep 30, 2005

A observational or N/A phase clinical study on Brain and Central Nervous System Tumors and Childhood Germ Cell Tumor, this trial is completed. The trial is conducted by Children's Oncology Group and has accumulated 6 data snapshots since 1992. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Jun 2018 — Jan 2021 [monthly]

    Completed

  5. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NANone

Show 1 earlier version
  1. Jan 2017 — Apr 2018 [monthly]

    Completed NA

    First recorded

Feb 1992

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Children's Oncology Group
  • National Cancer Institute (NCI)
Data source: Children's Oncology Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Asheville, United States, Atlanta, United States, Burlington, United States, Charleston, United States, Charlotte, United States, Dallas, United States, Detroit, United States, Flint, United States, Gainesville, United States, Geneva, Switzerland and 19 more location s